Viewing Study NCT07270835


Ignite Creation Date: 2025-12-24 @ 10:09 PM
Ignite Modification Date: 2025-12-25 @ 7:45 PM
Study NCT ID: NCT07270835
Status: RECRUITING
Last Update Posted: 2025-12-08
First Post: 2025-11-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Zanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
Sponsor: The First Affiliated Hospital of Soochow University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module